Avidity Partners Management LP 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:42 am Purchase |
2024-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 502,600 6.900% |
55 (+0.01%) |
Filing |
| 2024-02-14 06:50 am Sale |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 502,545 6.900% |
-175,695 (-25.90%) |
Filing |
| 2023-02-14 3:44 pm Purchase |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 678,240 9.900% |
355,420 (+110.10%) |
Filing |
| 2022-01-03 12:09 pm Purchase |
2021-12-30 | 13G | Kezar Life Sciences, Inc. KZR |
Avidity Partners Management LP | 322,820 6.600% |
322,820 (New Position) |
Filing |